MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 05-23-2026
Accelerate Diagnostics ROE Ratio 2011-2026 | AXDX
Annual ROE Ratio Accelerate Diagnostics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89.3 | 309.83 | 280.69 | 65.02 | 124.51 | 1142.5 | -153.95 | -53.94 | -85.3 | -34.2 | -46.87 | -36.81 | -35.8 | -7.87 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1142.5 | -153.95 | 111.22 |
Quarterly ROE Ratio Accelerate Diagnostics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116.01 | 170.48 | 180.64 | 125.44 | 284.59 | 317.08 | 256.43 | 213.06 | 278.08 | 141.54 | 142.72 | 155.23 | 120.32 | 135.47 | 156.38 | 212.74 | 471.77 | 234.06 | 102.03 | -41.4 | -369.21 | -197.82 | -142.25 | -111.25 | -86.3 | -70.89 | -58.0 | -59.0 | -66.0 | -71.83 | -77.26 | -69.31 | -58.47 | -67.34 | -75.15 | -77.68 | -81.07 | -65.43 | -50.96 | -49.24 | -48.38 | -44.63 | -47.99 | -43.06 | -33.31 | -34.53 | -28.24 | -29.0 | -26.91 | -26.49 | -18.21 | -17.91 | -9.24 | 0.85 | -8.94 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 471.77 | -369.21 | 26.4 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
-5.13 | $ 20.15 | -1.9 % | $ 584 M |  USA |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
Guardant Health
GH
|
419.21 | $ 118.95 | 0.8 % | $ 14.9 B | USA |
 |
Fulgent Genetics
FLGT
|
-5.44 | $ 17.11 | -1.55 % | $ 517 M | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 116.78 | 0.18 % | $ 9.63 B |  Irlanda |
 |
Agilent Technologies
A
|
22.45 | $ 114.96 | 0.15 % | $ 34.9 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 138.23 | -3.02 % | $ 6.46 B | USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 5.07 | 36.66 % | $ 6.74 M | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 21.63 | 0.28 % | $ 1.15 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 144.41 | -0.29 % | $ 23 B | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.82 | 1.11 % | $ 8.05 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 103.0 | 9.03 % | $ 6.95 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 432.8 | 0.63 % | $ 12.5 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 103.09 | 1.16 % | $ 22.7 B |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-656.53 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 160.3 | 0.91 % | $ 7.95 B | USA |
 |
Personalis
PSNL
|
-31.12 | $ 8.47 | 2.67 % | $ 756 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 9.23 | 1.32 % | $ 1.18 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 19.08 | 0.21 % | $ 427 M | USA |
 |
Natera
NTRA
|
-77.62 | $ 203.19 | -0.25 % | $ 20 B | USA |
 |
Myriad Genetics
MYGN
|
-99.46 | $ 3.82 | -2.3 % | $ 354 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 26.95 | -0.74 % | $ 25.6 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-113.19 | $ 6.34 | 2.92 % | $ 265 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 60.57 | 2.95 % | $ 3.62 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.49 | 2.05 % | $ 5.72 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 259.93 | 1.63 % | $ 21.6 B | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 448.28 | -0.24 % | $ 169 B | USA |
 |
Trinity Biotech plc
TRIB
|
88.73 | $ 0.6 | -3.7 % | $ 216 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 8.9 | 0.45 % | $ 1.93 B | USA |
 |
Waters Corporation
WAT
|
25.09 | $ 342.37 | 0.4 % | $ 20.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 195.21 | 0.72 % | $ 21.7 B | USA |